Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10554111 | Journal of Pharmaceutical and Biomedical Analysis | 2005 | 6 Pages |
Abstract
A method for the simultaneous determination of pyrimethamine, sulfadiazine and its metabolite N-acetyl-sulfadiazine in small plasma samples from neonates in treatment for congenital toxoplasmosis has been developed. In this method only 25 μl of plasma is used and a simple sample preparation based on protein precipitation and centrifugation provides highly reliable data as the recovery is about 100% and the precision is good. The analysis is performed using high performance liquid chromatography with UV and mass spectrometric (MS) detection. Pyrimethamine was found to give a linear response using MS detection in the range 0.02-5 μg/ml. Sulfadiazine and its metabolite N-acetyl-sulfadiazine were preferably analysed by UV at 269 nm in the concentration ranges 0.2-200 μg/ml for sulfadiazine and 0.2-50 μg/ml for N-acetyl-sulfadiazine.
Related Topics
Physical Sciences and Engineering
Chemistry
Analytical Chemistry
Authors
Jane Krogh Johannessen, Ida Christiansen, Dorte Remmer Schmidt, Eskild Petersen, Steen Honoré Hansen,